Metformin Ameliorates Epithelial–Mesenchymal Transition of Renal Tubular Epithelial Cells in Diabetes by Increasing Vitamin D Receptor Expression

BACKGROUND: Metformin is used as a first-line drug for the treatment of type 2 diabetes. Epithelial–mesenchymal transition (EMT) plays a significant role in the development of renal tubular damage in diabetic kidney disease. However, the underlying mechanisms of EMT in diabetic kidney disease are un...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Wenjie, Huang, Bin, Ye, Shandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792813/
https://www.ncbi.nlm.nih.gov/pubmed/36582506
http://dx.doi.org/10.2147/DMSO.S389918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792813/
https://www.ncbi.nlm.nih.gov/pubmed/36582506
http://dx.doi.org/10.2147/DMSO.S389918

Ejemplares similares